Mechanism of Baxian Huazhuo Decoction in the Treatment of Gouty Arthritis Based on Network Pharmacology, Molecular Docking, and Experimental Verification
Biomedical Chromatography · 2026-06 · 40 (6)
DOI: 10.1002/bmc.70456 ↗Kurz gefasst
Fachartikel in der Zeitschrift Biomedical Chromatography, online erschienen am 16.04.2026. Verfasst von Liting Mu und 6 weiteren Autor:innen. Beteiligte Einrichtung: School of Pharmacy, Jiamusi University, Jiamusi, China. Hauptthemen laut MEDLINE: Drugs, Chinese Herbal, Arthritis, Gouty. Die Arbeit nennt 35 Literaturangaben. Gefördert von: Basic Scientific Research Project of the Department of Education of Heilongjiang Province: Construction and Biological Performance Study of Porous Titanium Sus….
Abstract (Originalsprache)
The global prevalence of gout continues to rise. Baxian Huazhuo Decoction (BHD) has demonstrated significant efficacy in the clinical treatment of acute gouty arthritis (AGA); however, its mechanism of action remains unclear. This study first employed network pharmacology analysis to identify the key components, targets, and pathways of BHD against AGA. Molecular docking studies validated the binding affinity between the components of BHD and their potential targets. Ultrahigh‐performance liquid chromatography–high‐resolution mass spectrometry (UHPLC–HRMS) was utilized to identify the active components in BHD and elucidate their fragmentation pathways. Subsequently, a monosodium urate crystal–induced AGA rabbit model was established to evaluate the in vivo therapeutic efficacy of BHD. The results revealed 62 predicted active components and 268 target molecules in BHD, identifying core constituents such as gentiopicroside, limonin, and indirubin, which exhibited high affinity for targets including MAPK1, PPARG, and IL‐6. In vivo experiments confirmed that BHD significantly suppressed the phosphorylation of MAPK1, reduced the levels of pro‐inflammatory factors such as TNF‐α and IL‐6, mitigated synovial damage, and inhibited the activation of the PI3K‐Akt signaling pathway. This study systematically elucidates the pharmacological basis and mechanisms of action of BHD in the treatment of AGA, providing a scientific basis for its clinical application.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- School of Pharmacy, Jiamusi University, Jiamusi, China.
- Heilongjiang Institute of Pharmaceutical Research, Jiamusi, China.
ORCID-Profile: Changhai Sun
Förderung
- Basic Scientific Research Project of the Department of Education of Heilongjiang Province: Construction and Biological Performance Study of Porous Titanium Sus…
Zitieren
APA
Mu, L., Guo, X., Sun, S., Ma, C., Wang, J., Sun, C., & Qiu, H. (2026). Mechanism of Baxian Huazhuo Decoction in the Treatment of Gouty Arthritis Based on Network Pharmacology, Molecular Docking, and Experimental Verification. Biomedical Chromatography, 40(6). https://doi.org/10.1002/bmc.70456
Vancouver
Mu L, Guo X, Sun S, Ma C, Wang J, Sun C, et al. Mechanism of Baxian Huazhuo Decoction in the Treatment of Gouty Arthritis Based on Network Pharmacology, Molecular Docking, and Experimental Verification. Biomedical Chromatography. 2026;40(6). doi:10.1002/bmc.70456
BibTeX
@article{Mu2026,
author = {Mu, Liting and Guo, Xin and Sun, Shiyuan and Ma, Chen and Wang, Jiayao and Sun, Changhai and Qiu, Hongbin},
title = {Mechanism of Baxian Huazhuo Decoction in the Treatment of Gouty Arthritis Based on Network Pharmacology, Molecular Docking, and Experimental Verification},
journal = {Biomedical Chromatography},
year = {2026},
volume = {40},
number = {6},
doi = {10.1002/bmc.70456}
}
EUVIMED